R M Hagan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R M Hagan

Showing results (41-50 of 45) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 45 results.

Journal of Medicinal Chemistry|October 30, 1992

Conformationally constrained tachykinin analogues: potent and highly selective neurokinin NK-2 receptor agonistsM J Deal, R M Hagan, S J Ireland, et al.

European Journal of Pharmacology|January 16, 1995

GR159897, a potent non-peptide antagonist at tachykinin NK2 receptorsI J Beresford, R L Sheldrick, D I Ball, et al.

Journal of Medicinal Chemistry|July 10, 1992

Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptorA B McElroy, S P Clegg, M J Deal, et al.

British Journal of Pharmacology|January 22, 2009

BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headacheK A Maubach, R J Davis, D E Clark, et al.

European Journal of Pharmacology|November 11, 1999

Novel non-indolic melatonin receptor agonists differentially entrain endogenous melatonin rhythm and increase its amplitudeW J Drijfhout, J B de Vries, E J Homan, et al.

Pageof 5

Search research articles

Showing results (41-50 of 45) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 45 results.

Journal of Medicinal Chemistry|October 30, 1992

Conformationally constrained tachykinin analogues: potent and highly selective neurokinin NK-2 receptor agonistsM J Deal, R M Hagan, S J Ireland, et al.

European Journal of Pharmacology|January 16, 1995

GR159897, a potent non-peptide antagonist at tachykinin NK2 receptorsI J Beresford, R L Sheldrick, D I Ball, et al.

Journal of Medicinal Chemistry|July 10, 1992

Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptorA B McElroy, S P Clegg, M J Deal, et al.

British Journal of Pharmacology|January 22, 2009

BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headacheK A Maubach, R J Davis, D E Clark, et al.

European Journal of Pharmacology|November 11, 1999

Novel non-indolic melatonin receptor agonists differentially entrain endogenous melatonin rhythm and increase its amplitudeW J Drijfhout, J B de Vries, E J Homan, et al.

Pageof 5